Effect of Physical ACtivity in Fingolimod Treated patiEnts (PACE) With

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05890885` - MS Fatigue and tDCS on Fatigue in Multiple Sclerosis	N/A
Completed	`NCT03185065` - Treatment of Fatigue With Methylphenidate, Modafinil and Amantadine in Multiple Sclerosis	Phase 3
Not yet recruiting	`NCT02286557` - Testing the Effects of Methylphenidate on Multiple Sclerosis	Phase 2

See also

Status

Clinical Trial

Phase

Recruiting

NCT05890885 - MS Fatigue and tDCS on Fatigue in Multiple Sclerosis

N/A

Completed

NCT03185065 - Treatment of Fatigue With Methylphenidate, Modafinil and Amantadine in Multiple Sclerosis

Phase 3

Not yet recruiting

NCT02286557 - Testing the Effects of Methylphenidate on Multiple Sclerosis

Phase 2

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT01490840
Study type	Interventional
Source	Novartis
Contact
Status	Completed
Phase	Phase 4
Start date	November 2011
Completion date	July 2014

Effect of Physical ACtivity in Fingolimod Treated patiEnts (PACE) With Relapsing-remitting Multiple Sclerosis — PACE

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms